WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Myra A. Sutanto Shen
Partner
Tax
Palo Alto
msutantoshen@wsgr.com

D650-565-3815

Download vCard
Open PDF
  • Broad Transactional Tax Practice

    Myra counsels public and private companies regarding federal income tax planning for a broad range of corporate transactions, including formations, financings and restructurings, equity offerings, and M&A. 

Myra Sutanto Shen is a tax partner in the Palo Alto office of Wilson Sonsini and the head of the firm's tax practice group. Myra represents technology and life science companies in connection with all aspects of U.S. federal income tax planning.  She has extensive experience advising public and private companies in all corporate transactions, including domestic and cross-border mergers and acquisitions, equity and debt financings, IPOs and convertible note offerings, and corporate restructurings. Myra also advises founders, investors, and companies regarding the “qualified small business stock” exemption under Section 1202 of the Internal Revenue Code.  

Myra participates in several firm committees, co-chairs the firm’s Diversity, Equity, and Inclusion Committee and is an active participant in Women of Wilson and the Asian American Affinity Group. 

Experience

Myra Sutanto Shen is a tax partner in the Palo Alto office of Wilson Sonsini and the head of the firm's tax practice group. Myra represents technology and life science companies in connection with all aspects of U.S. federal income tax planning.  She has extensive experience advising public and private companies in all corporate transactions, including domestic and cross-border mergers and acquisitions, equity and debt financings, IPOs and convertible note offerings, and corporate restructurings. Myra also advises founders, investors, and companies regarding the “qualified small business stock” exemption under Section 1202 of the Internal Revenue Code.  

Myra participates in several firm committees, co-chairs the firm’s Diversity, Equity, and Inclusion Committee and is an active participant in Women of Wilson and the Asian American Affinity Group. 

Education
  • J.D., Northwestern Pritzker School of Law, 2007Cum Laude; Production Editor, Journal of Criminal Law and Criminology
  • B.A., Integrated Science and Biology, Northwestern University, 2002Cum Laude, With Honors
Associations and Memberships
  • Vice Chair, Corporate Tax Committee, Member, Taxation Section, American Bar Association
  • Member, Taxation Section, State Bar of California
Honors
  • Recognized in the California: Northern Tax category in the 2025-2026 editions of Chambers USA
  • Named to the 2014-2017 editions of the "Rising Stars" list published by Northern California Super Lawyers
Admissions
  • State Bar of California
Credentials
Education
  • J.D., Northwestern Pritzker School of Law, 2007Cum Laude; Production Editor, Journal of Criminal Law and Criminology
  • B.A., Integrated Science and Biology, Northwestern University, 2002Cum Laude, With Honors
Associations and Memberships
  • Vice Chair, Corporate Tax Committee, Member, Taxation Section, American Bar Association
  • Member, Taxation Section, State Bar of California
Honors
  • Recognized in the California: Northern Tax category in the 2025-2026 editions of Chambers USA
  • Named to the 2014-2017 editions of the "Rising Stars" list published by Northern California Super Lawyers
Admissions
  • State Bar of California

Select Publications

  • Co-author with R. Sherrill, “Eligibility of Life Sciences Companies for Qualified Small Business Stock,” The Life Sciences Report, Wilson Sonsini, January 2025
  • "Calif. Budget Will Likely Have Unexpected Tax Consequences," Law360, June 12, 2024
  • “Tax Considerations for UK Tech Companies (US Guide),” Department for Business and Trade, January 2024

  • Co-author, "Video Game NFTs: Top Legal Considerations for Developers," The Licensing Journal, March 2022
  • Co-author, “USA” chapter, Corporate Tax, Seventh and Eighth Editions, Global Legal Insights, 2019-2020
  • Co-author with D. Glazer, "The UK Startup's Guide to Navigating the U.S. Tax Implications of U.S. VC Investment," Notion Capital Insights, December 13, 2017
  • "The Other Holding Period: Qualified Small Business Stock and the Magic of Five Years," M&A Tax Report, November 2016
  • Co-author with I. Humphreys, "Acquisition Learnings from the Cap Gemini Cases," M&A Tax Report, September 2009


Select Speaking Engagements

  • Moderator, “Dealing with Section 269, A Transactional Approach,” ABA Section of Tax 2025 May Meeting, May 9, 2025 
  • Panelist, "What's New in M&A,” High Tech Tax Institute, November 4, 2024 
  • "Asset Sale vs. Stock Sale: Tax Considerations, Advanced Drafting, and Structuring Techniques for Tax Counsel," Strafford webinar, February 22, 2024
  • Panelist, "M&A Deals - What's New,” High Tech Tax Institute, November 7, 2023
  • Panelist, "M&A and Financing Trends,” High Tech Tax Institute, November 8, 2022
  • Panelist, "Trends in M&A,” California Lawyers Association 2022 Annual Meeting of the Tax Bar and Tax Policy Conference, November 3, 2022
  • Panelist, “Financing Developments and Tax Considerations,” High Tech Tax Institute, November 8, 2021
  • Panelist, “Current Developments in Corporate Taxation,” American Bar Association, September 20, 2021
  • Panelist, “Dealing with Losses: CARES Act Changes, Debt Restructuring and Other Strategies for a Strong Future,” High Tech Tax Institute, November 10, 2020
  • “The 2017 Tax Act’s Impact on Emerging Growth Enterprises and Start-Ups,” Practicing Law Institute, On-Demand One-Hour Briefing, April 23, 2019
  • "Qualified Small Business Stock Trends in Venture Financings and Mergers and Acquisitions," Practicing Law Institute, On-Demand One-Hour Briefing, August 3, 2017
Insights

Select Publications

  • Co-author with R. Sherrill, “Eligibility of Life Sciences Companies for Qualified Small Business Stock,” The Life Sciences Report, Wilson Sonsini, January 2025
  • "Calif. Budget Will Likely Have Unexpected Tax Consequences," Law360, June 12, 2024
  • “Tax Considerations for UK Tech Companies (US Guide),” Department for Business and Trade, January 2024

  • Co-author, "Video Game NFTs: Top Legal Considerations for Developers," The Licensing Journal, March 2022
  • Co-author, “USA” chapter, Corporate Tax, Seventh and Eighth Editions, Global Legal Insights, 2019-2020
  • Co-author with D. Glazer, "The UK Startup's Guide to Navigating the U.S. Tax Implications of U.S. VC Investment," Notion Capital Insights, December 13, 2017
  • "The Other Holding Period: Qualified Small Business Stock and the Magic of Five Years," M&A Tax Report, November 2016
  • Co-author with I. Humphreys, "Acquisition Learnings from the Cap Gemini Cases," M&A Tax Report, September 2009


Select Speaking Engagements

  • Moderator, “Dealing with Section 269, A Transactional Approach,” ABA Section of Tax 2025 May Meeting, May 9, 2025 
  • Panelist, "What's New in M&A,” High Tech Tax Institute, November 4, 2024 
  • "Asset Sale vs. Stock Sale: Tax Considerations, Advanced Drafting, and Structuring Techniques for Tax Counsel," Strafford webinar, February 22, 2024
  • Panelist, "M&A Deals - What's New,” High Tech Tax Institute, November 7, 2023
  • Panelist, "M&A and Financing Trends,” High Tech Tax Institute, November 8, 2022
  • Panelist, "Trends in M&A,” California Lawyers Association 2022 Annual Meeting of the Tax Bar and Tax Policy Conference, November 3, 2022
  • Panelist, “Financing Developments and Tax Considerations,” High Tech Tax Institute, November 8, 2021
  • Panelist, “Current Developments in Corporate Taxation,” American Bar Association, September 20, 2021
  • Panelist, “Dealing with Losses: CARES Act Changes, Debt Restructuring and Other Strategies for a Strong Future,” High Tech Tax Institute, November 10, 2020
  • “The 2017 Tax Act’s Impact on Emerging Growth Enterprises and Start-Ups,” Practicing Law Institute, On-Demand One-Hour Briefing, April 23, 2019
  • "Qualified Small Business Stock Trends in Venture Financings and Mergers and Acquisitions," Practicing Law Institute, On-Demand One-Hour Briefing, August 3, 2017
Focus Areas
  • Biotech
  • Life Sciences
  • Medical Devices
  • Tax
Recent Insights
Client Highlights
Firm Advises 4E Therapeutics on Acquisition by Eli Lilly
On June 16, 2026, 4E Therapeutics, an Austin-based neuroscience company developing next-generation treatments for chronic pain, announced that it has been acquired by Eli Lilly and Company. Wilson Sonsini Goodrich & Rosati advised 4E Therapeutics on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Beren Therapeutics P.B.C. on $300 Million Financing, Including Equity and Debt and Royalty Facilities
On June 10, 2026, Beren Therapeutics P.B.C., a leader in cholesterol trafficking biology and cyclodextrin-based therapeutics, announced it has secured $300 million in combined financing. The financing consists of:
Learn More
View All
Recent Events
WSGR Events
Biotech's New Playbook: Spinouts and Optionality
Biotechnology companies are increasingly using single-asset spinouts as a way to create value, though the approach can be complex. This afternoon forum will examine considerations to strategically design and execute a successful spinout. Attendees will gain insight into the legal foundations of these transactions, including tax considerations, patent strategy, IP allocation, and structural design. The program will also explore the broader business drivers behind spinout decisions—such as capital formation, strategic focus, partnership alignment, governance, and long-term value creation.
Learn More
Speaking Engagements
ABA Section of Taxation 2026 May Meeting
The May Tax Meeting is the Section’s largest and the premier event for lawyers interested in all aspects of tax law. Join us in Washington, DC to learn from and meet with the country's leading tax attorneys and government officials, discussing the latest federal, state, and local tax policies and more.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.